1601 12th Avenue South,
Birmingham, Alabama 35205
Vivo Biosciences, Inc. is a developer of a patented "all-human" bioassay platform, HuBiogel, which allows for rapid analysis of drug efficacy, toxicity and therapy prediction in the preclinical research, drug discovery and therapeutics markets.
Vivo Biosciences was acquired by LifeNet Health on November 02, 2016.
Join Mergr to view all 274 acquisitions of life science companies in 2016, including 23 acquisitions by private equity firms, and 251 by strategics.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Vivo Biosciences.
No obligation. Cancel anytime.